Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer
Results from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term androgen deprivation (STAD) did not meet its primary endpoint of improving ...
Apr 28, 2023
0
4